Table 5. Survival among transplant patients with toxoplasmosis, according to patients’ characteristics, Europe, 2010–2014.
| Characteristic |
2-mo survival |
|
6-mo survival | ||
|---|---|---|---|---|---|
| No. patients/no. survived (%) |
p value* |
No. patients/no. survived (%) |
p value* |
||
| All patients |
61/87 (70) |
Not applicable |
|
46/87 (53) |
Not applicable |
| Chemoprophylaxis | |||||
| Yes | 30/35 (86) | <0.05 | 26/35 (74) | <0.01 | |
| No |
27/43 (63) |
|
|
16/43 (37) |
|
| Recipient serologic status | |||||
| Positive | 27/45 (60) | <0.05 | 15/45 (33) | <0.001 | |
| Negative |
22/25 (88) |
|
|
20/25 (80) |
|
| Type of graft | |||||
| Hematopoietic stem cell | 36/58 (62) | <0.05 | 22/58 (38) | <0.001 | |
| Solid organ | 25/29 (86) | 24/29 (83) | |||
*Exact χ2 test.